<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36163485</PMID><DateCompleted><Year>2022</Year><Month>09</Month><Day>28</Day></DateCompleted><DateRevised><Year>2022</Year><Month>11</Month><Day>23</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Sep</Month><Day>26</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Motor unit number index (MUNIX) in the D50 disease progression model reflects disease accumulation independently of disease aggressiveness in ALS.</ArticleTitle><Pagination><StartPage>15997</StartPage><MedlinePgn>15997</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">15997</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-022-19911-0</ELocationID><Abstract><AbstractText>The neurophysiological technique motor unit number index (MUNIX) is increasingly used in clinical trials to measure loss of motor units. However, the heterogeneous disease course in amyotrophic lateral sclerosis (ALS) obfuscates robust correlations between clinical status and electrophysiological assessments. To address this heterogeneity, MUNIX was applied in the D50 disease progression model by analyzing disease aggressiveness (D50) and accumulation (rD50 phase) in ALS separately. 237 ALS patients, 45 controls and 22 ALS-Mimics received MUNIX of abductor pollicis brevis (APB), abductor digiti minimi (ADM) and tibialis anterior (TA) muscles. MUNIX significantly differed between controls and ALS patients and between ALS-Mimics and controls. Within the ALS cohort, significant differences between Phase I and II revealed in MUNIX, compound muscle action potential (CMAP) and motor unit size index (MUSIX) of APB as well as in MUNIX and CMAP of TA. For the ADM, significant differences occurred later in CMAP and MUNIX between Phase II and III/IV. In contrast, there was no significant association between disease aggressiveness and MUNIX. In application of the D50 disease progression model, MUNIX can demonstrate disease accumulation already in early Phase I and evaluate effects of therapeutic interventions in future therapeutic trials independent of individual disease aggressiveness.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Ebersbach</LastName><ForeName>Theresa</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Neurology, Jena University Hospital, Am Klinikum 1, 07747, Jena, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Roediger</LastName><ForeName>Annekathrin</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurology, Jena University Hospital, Am Klinikum 1, 07747, Jena, Germany. annekathrin.roediger@med.uni-jena.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Steinbach</LastName><ForeName>Robert</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Neurology, Jena University Hospital, Am Klinikum 1, 07747, Jena, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Appelfeller</LastName><ForeName>Martin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurology, Jena University Hospital, Am Klinikum 1, 07747, Jena, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tuemmler</LastName><ForeName>Anke</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurology, Jena University Hospital, Am Klinikum 1, 07747, Jena, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stubendorff</LastName><ForeName>Beatrice</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Neurology, Jena University Hospital, Am Klinikum 1, 07747, Jena, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schuster</LastName><ForeName>Simon</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Precision Neurology, University of L&#xfc;beck, L&#xfc;beck, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Herdick</LastName><ForeName>Meret</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Precision Neurology, University of L&#xfc;beck, L&#xfc;beck, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Axer</LastName><ForeName>Hubertus</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Neurology, Jena University Hospital, Am Klinikum 1, 07747, Jena, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Witte</LastName><ForeName>Otto W</ForeName><Initials>OW</Initials><AffiliationInfo><Affiliation>Department of Neurology, Jena University Hospital, Am Klinikum 1, 07747, Jena, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Healthy Ageing, Jena University Hospital, Jena, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grosskreutz</LastName><ForeName>Julian</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Precision Neurology, University of L&#xfc;beck, L&#xfc;beck, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Healthy Ageing, Jena University Hospital, Jena, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>09</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000200" MajorTopicYN="N">Action Potentials</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001132" MajorTopicYN="N">Arm</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004576" MajorTopicYN="N">Electromyography</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018482" MajorTopicYN="N">Muscle, Skeletal</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>7</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>9</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>9</Month><Day>27</Day><Hour>0</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>9</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>10</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36163485</ArticleId><ArticleId IdType="pmc">PMC9512899</ArticleId><ArticleId IdType="doi">10.1038/s41598-022-19911-0</ArticleId><ArticleId IdType="pii">10.1038/s41598-022-19911-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>van Es MA, et al. Amyotrophic lateral sclerosis. Lancet. 2017;390:2084&#x2013;2098. doi: 10.1016/S0140-6736(17)31287-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(17)31287-4</ArticleId><ArticleId IdType="pubmed">28552366</ArticleId></ArticleIdList></Reference><Reference><Citation>Masrori P, Van Damme P. Amyotrophic lateral sclerosis: A clinical review. Eur. J. Neurol. 2020 doi: 10.1111/ene.14393.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.14393</ArticleId><ArticleId IdType="pmc">PMC7540334</ArticleId><ArticleId IdType="pubmed">32526057</ArticleId></ArticleIdList></Reference><Reference><Citation>Nandedkar SD, Nandedkar DS, Barkhaus PE, Stalberg EV. Motor unit number index (MUNIX) IEEE Trans. Biomed. Eng. 2004;51:2209&#x2013;2211. doi: 10.1109/TBME.2004.834281.</Citation><ArticleIdList><ArticleId IdType="doi">10.1109/TBME.2004.834281</ArticleId><ArticleId IdType="pubmed">15605872</ArticleId></ArticleIdList></Reference><Reference><Citation>Nandedkar SD, Barkhaus PE, Stalberg EV. Motor unit number index (MUNIX): Principle, method, and findings in healthy subjects and in patients with motor neuron disease. Muscle Nerv. 2010;42:798&#x2013;807. doi: 10.1002/mus.21824.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.21824</ArticleId><ArticleId IdType="pubmed">20976783</ArticleId></ArticleIdList></Reference><Reference><Citation>Nandedkar SD, Barkhaus PE, Stalberg EV, Neuwirth C, Weber M. Motor unit number index: Guidelines for recording signals and their analysis. Muscle Nerv. 2018;58:374&#x2013;380. doi: 10.1002/mus.26099.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.26099</ArticleId><ArticleId IdType="pubmed">29427557</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuwirth C, et al. Quality control of motor unit number index (MUNIX) measurements in 6 muscles in a single-subject &#x201c;round-robin&#x201d; setup. PLoS&#xa0;ONE. 2016;11:e0153948. doi: 10.1371/journal.pone.0153948.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0153948</ArticleId><ArticleId IdType="pmc">PMC4852906</ArticleId><ArticleId IdType="pubmed">27135747</ArticleId></ArticleIdList></Reference><Reference><Citation>de Carvalho M, Barkhaus PE, Nandedkar SD, Swash M. Motor unit number estimation (MUNE): Where are we now? Clin. Neurophysiol. 2018;129:1507&#x2013;1516. doi: 10.1016/j.clinph.2018.04.748.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2018.04.748</ArticleId><ArticleId IdType="pubmed">29804042</ArticleId></ArticleIdList></Reference><Reference><Citation>Fatehi F, Grapperon AM, Fathi D, Delmont E, Attarian S. The utility of motor unit number index: A systematic review. Neurophysiol. Clin. 2018;48:251&#x2013;259. doi: 10.1016/j.neucli.2018.09.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neucli.2018.09.001</ArticleId><ArticleId IdType="pubmed">30287192</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuwirth C, et al. Implementing motor unit number index (MUNIX) in a large clinical trial: Real world experience from 27 centres. Clin. Neurophysiol. 2018;129:1756&#x2013;1762. doi: 10.1016/j.clinph.2018.04.614.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2018.04.614</ArticleId><ArticleId IdType="pubmed">29803404</ArticleId></ArticleIdList></Reference><Reference><Citation>Alix JJP, et al. Assessment of the reliability of the motor unit size index (MUSIX) in single subject &#x201c;round-robin&#x201d; and multi-centre settings. Clin. Neurophysiol. 2019;130:666&#x2013;674. doi: 10.1016/j.clinph.2019.01.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2019.01.020</ArticleId><ArticleId IdType="pubmed">30870802</ArticleId></ArticleIdList></Reference><Reference><Citation>Bashford J, Mills K, Shaw C. The evolving role of surface electromyography in amyotrophic lateral sclerosis: A systematic review. Clin. Neurophysiol. 2020;131:942&#x2013;950. doi: 10.1016/j.clinph.2019.12.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2019.12.007</ArticleId><ArticleId IdType="pmc">PMC7083223</ArticleId><ArticleId IdType="pubmed">32044239</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuwirth C, et al. Motor unit number index (MUNIX) detects motor neuron loss in pre-symptomatic muscles in amyotrophic lateral sclerosis. Clin. Neurophysiol. 2017;128:495&#x2013;500. doi: 10.1016/j.clinph.2016.11.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2016.11.026</ArticleId><ArticleId IdType="pubmed">28043769</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuwirth C, et al. Tracking motor neuron loss in a set of six muscles in amyotrophic lateral sclerosis using the motor unit number index (MUNIX): A 15-month longitudinal multicentre trial. J. Neurol. Neurosurg. Psychiatry. 2015;86:1172&#x2013;1179. doi: 10.1136/jnnp-2015-310509.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2015-310509</ArticleId><ArticleId IdType="pubmed">25935892</ArticleId></ArticleIdList></Reference><Reference><Citation>Gawel M, Kuzma-Kozakiewicz M. Does the MUNIX method reflect clinical dysfunction in amyotrophic lateral sclerosis: A practical experience. Medicine (Baltimore) 2016;95:e3647. doi: 10.1097/MD.0000000000003647.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000003647</ArticleId><ArticleId IdType="pmc">PMC4902529</ArticleId><ArticleId IdType="pubmed">27175687</ArticleId></ArticleIdList></Reference><Reference><Citation>Grimaldi S, et al. Global motor unit number index sum score for assessing the loss of lower motor neurons in amyotrophic lateral sclerosis. Muscle Nerv. 2017;56:202&#x2013;206. doi: 10.1002/mus.25595.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.25595</ArticleId><ArticleId IdType="pubmed">28164325</ArticleId></ArticleIdList></Reference><Reference><Citation>Cedarbaum JM, et al. The ALSFRS-R: A revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS study group (Phase III) J. Neurol. Sci. 1999;169:13&#x2013;21. doi: 10.1016/s0022-510x(99)00210-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0022-510x(99)00210-5</ArticleId><ArticleId IdType="pubmed">10540002</ArticleId></ArticleIdList></Reference><Reference><Citation>Poesen K, et al. Neurofilament markers for ALS correlate with extent of upper and lower motor neuron disease. Neurology. 2017;88:2302&#x2013;2309. doi: 10.1212/WNL.0000000000004029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000004029</ArticleId><ArticleId IdType="pubmed">28500227</ArticleId></ArticleIdList></Reference><Reference><Citation>Steinbach R, et al. Disease aggressiveness signatures of amyotrophic lateral sclerosis in white matter tracts revealed by the D50 disease progression model. Hum. Brain Mapp. 2020 doi: 10.1002/hbm.25258.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hbm.25258</ArticleId><ArticleId IdType="pmc">PMC7814763</ArticleId><ArticleId IdType="pubmed">33103324</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuwirth C, Nandedkar S, Stalberg E, Weber M. Motor unit number index (MUNIX): A novel neurophysiological technique to follow disease progression in amyotrophic lateral sclerosis. Muscle Nerv. 2010;42:379&#x2013;384. doi: 10.1002/mus.21707.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.21707</ArticleId><ArticleId IdType="pubmed">20589888</ArticleId></ArticleIdList></Reference><Reference><Citation>Shefner JM, et al. A proposal for new diagnostic criteria for ALS. Clin. Neurophysiol. 2020;131:1975&#x2013;1978. doi: 10.1016/j.clinph.2020.04.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2020.04.005</ArticleId><ArticleId IdType="pubmed">32387049</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon PH, et al. Progression in ALS is not linear but is curvilinear. J. Neurol. 2010;257:1713&#x2013;1717. doi: 10.1007/s00415-010-5609-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-010-5609-1</ArticleId><ArticleId IdType="pubmed">20532545</ArticleId></ArticleIdList></Reference><Reference><Citation>Franchignoni F, Mora G, Giordano A, Volanti P, Chio A. Evidence of multidimensionality in the ALSFRS-R Scale: A critical appraisal on its measurement properties using Rasch analysis. J. Neurol. Neurosurg. Psychiatry. 2013;84:1340&#x2013;1345. doi: 10.1136/jnnp-2012-304701.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2012-304701</ArticleId><ArticleId IdType="pubmed">23516308</ArticleId></ArticleIdList></Reference><Reference><Citation>Thakore NJ, Lapin BR, Pioro EP, Pooled Resource Open-Access ALS Clinical Trial Consortium Trajectories of impairment in amyotrophic lateral sclerosis: Insights from the pooled resource open-access ALS clinical trials cohort. Muscle Nerv. 2018;57:937&#x2013;945. doi: 10.1002/mus.26042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.26042</ArticleId><ArticleId IdType="pubmed">29244213</ArticleId></ArticleIdList></Reference><Reference><Citation>Steinbach R, et al. Applying the D50 disease progression model to gray and white matter pathology in amyotrophic lateral sclerosis. Neuroimage Clin. 2020;25:102094. doi: 10.1016/j.nicl.2019.102094.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2019.102094</ArticleId><ArticleId IdType="pmc">PMC6940701</ArticleId><ArticleId IdType="pubmed">31896467</ArticleId></ArticleIdList></Reference><Reference><Citation>Dreger M, et al. Cerebrospinal fluid neurofilament light chain (NfL) predicts disease aggressiveness in amyotrophic lateral sclerosis: An application of the d50 disease progression model. Front. Neurosci. 2021;15:651651. doi: 10.3389/fnins.2021.651651.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2021.651651</ArticleId><ArticleId IdType="pmc">PMC8056017</ArticleId><ArticleId IdType="pubmed">33889072</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuwirth C, et al. Motor unit number index (MUNIX): Reference values of five different muscles in healthy subjects from a multi-centre study. Clin. Neurophysiol. 2011;122:1895&#x2013;1898. doi: 10.1016/j.clinph.2011.05.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2011.05.014</ArticleId><ArticleId IdType="pubmed">21689981</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao B, et al. Reference values for the motor unit number index and the motor unit size index in five muscles. Muscle Nerv. 2020;61:657&#x2013;661. doi: 10.1002/mus.26837.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.26837</ArticleId><ArticleId IdType="pubmed">32068896</ArticleId></ArticleIdList></Reference><Reference><Citation>Delmont E, et al. Motor unit number index as an individual biomarker: Reference limits of intra-individual variability over time in healthy subjects. Clin. Neurophysiol. 2020;131:2209&#x2013;2215. doi: 10.1016/j.clinph.2020.06.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2020.06.019</ArticleId><ArticleId IdType="pubmed">32707479</ArticleId></ArticleIdList></Reference><Reference><Citation>Chio A, et al. Phenotypic heterogeneity of amyotrophic lateral sclerosis: A population based study. J. Neurol. Neurosurg. Psychiatry. 2011;82:740&#x2013;746. doi: 10.1136/jnnp.2010.235952.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2010.235952</ArticleId><ArticleId IdType="pubmed">21402743</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks BR, Miller RG, Swash M, Munsat TL. El escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Other Motor Neuron Disord. 2000;1:293&#x2013;299. doi: 10.1080/146608200300079536.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/146608200300079536</ArticleId><ArticleId IdType="pubmed">11464847</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilbourn AJ. The, &#x201c;split hand syndrome&#x201d;. Muscle Nerv. 2000;23:138. doi: 10.1002/(sici)1097-4598(200001)23:1&lt;138::aid-mus22&gt;3.0.co;2-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(sici)1097-4598(200001)23:1&lt;138::aid-mus22&gt;3.0.co;2-7</ArticleId><ArticleId IdType="pubmed">10590421</ArticleId></ArticleIdList></Reference><Reference><Citation>Eisen A, Kuwabara S. The split hand syndrome in amyotrophic lateral sclerosis. J. Neurol. Neurosurg. Psychiatry. 2012;83:399&#x2013;403. doi: 10.1136/jnnp-2011-301456.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2011-301456</ArticleId><ArticleId IdType="pubmed">22100761</ArticleId></ArticleIdList></Reference><Reference><Citation>Corcia P, et al. Split-hand and split-limb phenomena in amyotrophic lateral sclerosis: Pathophysiology, electrophysiology and clinical manifestations. J. Neurol. Neurosurg. Psychiatry. 2021;92:1126&#x2013;1130. doi: 10.1136/jnnp-2021-326266.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2021-326266</ArticleId><ArticleId IdType="pubmed">34285065</ArticleId></ArticleIdList></Reference><Reference><Citation>Chio A, Hammond ER, Mora G, Bonito V, Filippini G. Development and evaluation of a clinical staging system for amyotrophic lateral sclerosis. J. Neurol. Neurosurg. Psychiatry. 2015;86:38&#x2013;44. doi: 10.1136/jnnp-2013-306589.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2013-306589</ArticleId><ArticleId IdType="pubmed">24336810</ArticleId></ArticleIdList></Reference><Reference><Citation>Roche JC, et al. A proposed staging system for amyotrophic lateral sclerosis. Brain. 2012;135:847&#x2013;852. doi: 10.1093/brain/awr351.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awr351</ArticleId><ArticleId IdType="pmc">PMC3286327</ArticleId><ArticleId IdType="pubmed">22271664</ArticleId></ArticleIdList></Reference><Reference><Citation>Bostock H, Jacobsen AB, Tankisi H. Motor unit number index and compound muscle action potential amplitude. Clin. Neurophysiol. 2019;130:1734&#x2013;1740. doi: 10.1016/j.clinph.2019.05.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2019.05.031</ArticleId><ArticleId IdType="pubmed">31288985</ArticleId></ArticleIdList></Reference><Reference><Citation>Philibert M, Grapperon AM, Delmont E, Attarian S. Monitoring the short-term effect of intravenous immunoglobulins in multifocal motor neuropathy using motor unit number index. Clin. Neurophysiol. 2017;128:235&#x2013;240. doi: 10.1016/j.clinph.2016.11.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2016.11.012</ArticleId><ArticleId IdType="pubmed">27988478</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>